Zhang DH - Search Results

1

Immunotherapy of Cancer by Targeting Regulatory T cells.

Chen BJ, Zhao JW, Zhang DH, Zheng AH, Wu GQ. Chen BJ, et al. Among authors: zhang dh. Int Immunopharmacol. 2022 Mar;104:108469. doi: 10.1016/j.intimp.2021.108469. Epub 2022 Jan 7. Int Immunopharmacol. 2022. PMID: 35008005 Free article. Review.

2

CD3 high and FoxP3 - tumor-infiltrating lymphocytes in the invasive margin as a favorable prognostic marker in patients with invasive urothelial carcinoma of the bladder.

Sun ZJ, Zhao JW, Zhao M, Chen Y, Zhang X, Li HC, Wu GQ, Zhang DH. Sun ZJ, et al. Among authors: zhang dh, zhang x. Anticancer Drugs. 2023 Aug 1;34(7):844-851. doi: 10.1097/CAD.0000000000001468. Epub 2022 Dec 5. Anticancer Drugs. 2023. PMID: 36563023

3

Mechanisms and strategies to enhance penetration during intravesical drug therapy for bladder cancer.

Zhang P, Wu G, Zhang D, Lai WF. Zhang P, et al. J Control Release. 2023 Feb;354:69-79. doi: 10.1016/j.jconrel.2023.01.001. Epub 2023 Jan 4. J Control Release. 2023. PMID: 36603810 Review.

4

Anti-PD-L1 antibody retains antitumour effects while mitigating immunotherapy-related colitis in bladder cancer-bearing mice after CT-mediated intratumoral delivery.

Wang YS, Zheng AH, Zhao JW, Gu HY, Meng ZN, Chen JY, Wang FW, Zhu XM, Chen Y, Xu SC, Sun LT, Lai WF, Wu GQ, Zhang DH. Wang YS, et al. Among authors: zhang dh. Int Immunopharmacol. 2024 Aug 20;137:112417. doi: 10.1016/j.intimp.2024.112417. Epub 2024 Jun 18. Int Immunopharmacol. 2024. PMID: 38897122

5

Advances in Research on Bladder Cancer Targeting Peptides: a Review.

Zheng B, Zhang P, Wang H, Wang J, Liu ZH, Zhang D. Zheng B, et al. Cell Biochem Biophys. 2021 Dec;79(4):711-718. doi: 10.1007/s12013-021-01019-3. Epub 2021 Sep 1. Cell Biochem Biophys. 2021. PMID: 34468956 Free PMC article. Review.

6

miR-199a-5p suppresses human bladder cancer cell metastasis by targeting CCR7.

Zhou M, Wang S, Hu L, Liu F, Zhang Q, Zhang D. Zhou M, et al. BMC Urol. 2016 Nov 4;16(1):64. doi: 10.1186/s12894-016-0181-3. BMC Urol. 2016. PMID: 27814720 Free PMC article.

7

MiR-125a-5p suppresses bladder cancer progression through targeting FUT4.

Zhang Y, Zhang D, Lv J, Wang S, Zhang Q. Zhang Y, et al. Biomed Pharmacother. 2018 Dec;108:1039-1047. doi: 10.1016/j.biopha.2018.09.100. Epub 2018 Sep 28. Biomed Pharmacother. 2018. PMID: 30372804 Free article.

8

NOTCH1 regulates the proliferation and migration of bladder cancer cells by cooperating with long non-coding RNA HCG18 and microRNA-34c-5p.

Xu Z, Huang B, Zhang Q, He X, Wei H, Zhang D. Xu Z, et al. J Cell Biochem. 2019 Apr;120(4):6596-6604. doi: 10.1002/jcb.27954. Epub 2018 Nov 13. J Cell Biochem. 2019. PMID: 30426533

9

Circulating Mucosal-Associated Invariant T Cells in a Large Cohort of Healthy Chinese Individuals From Newborn to Elderly.

Chen P, Deng W, Li D, Zeng T, Huang L, Wang Q, Wang J, Zhang W, Yu X, Duan D, Wang J, Xia H, Chen H, Huang W, Li J, Zhang D, Zhong XP, Gao J. Chen P, et al. Front Immunol. 2019 Feb 19;10:260. doi: 10.3389/fimmu.2019.00260. eCollection 2019. Front Immunol. 2019. PMID: 30838000 Free PMC article.

10

Targeting TR4 nuclear receptor with antagonist bexarotene increases docetaxel sensitivity to better suppress the metastatic castration-resistant prostate cancer progression.

Hu L, Sun Y, Luo J, He X, Ye M, Li G, Zhang Y, Bai J, Zhang D, Chang C. Hu L, et al. Oncogene. 2020 Feb;39(9):1891-1903. doi: 10.1038/s41388-019-1070-5. Epub 2019 Nov 20. Oncogene. 2020. PMID: 31748715 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

772 results

Search Page

Filters